Proteomic identification of heat shock protein 27 as a differentiation and prognostic marker in neuroblastoma but not in Ewing's sarcoma

Virchows Archiv

Volumn 452, Issue 2, 2008, Pages 157-167

  Zanini, Cristina ^a   Pulerà, Francesco ^b   Carta, Franco ^a   Giribaldi, Giuliana ^a   Mandili, Giorgia ^a   Maule, Milena Maria ^a   Forni, Marco ^b   Turrini, Franco ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

Author keywords

Ewing's sarcoma; Gene expression; HSP; Immunohistochemistry; Neuroblastoma; Proteomic

Indexed keywords

HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; RETINOIC ACID;

AMINO ACID SEQUENCE; ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; DISEASE MARKER; EWING SARCOMA; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEOMICS; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TWO DIMENSIONAL ELECTROPHORESIS; VALIDATION STUDY;

ADOLESCENT; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CHILD; CHILD, PRESCHOOL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; INFANT, NEWBORN; KIDNEY NEOPLASMS; NEUROBLASTOMA; PROGNOSIS; PROTEOMICS; SARCOMA, EWING'S; TRETINOIN; TUMOR MARKERS, BIOLOGICAL;

EID: 39149118926     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-007-0549-6     Document Type: Article

References (38)

1. Armstrong BK, White E, Saracci R (1992) Principles exposure measurement in epidemiology. Oxford University Press, New York, pp 66-67
2. Bando Y, Katayama T, Kasai K, Taniguchi M, Tamatani M, Tohyama M (2003) GRP94 (94 kDa glucose-regulated protein) suppresses ischemic neuronal cell death against ischemia/reperfusion injury. Eur J Neurosi 18:829-40
3. Biedler JL, Roffler-Tarlov S, Shachner M, Freedman LS (1978) Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 38:3751-3757
4. Biedler JL, Spengler BA, Chang TD, Ross RA (1988) Transdifferentiation of human neuroblastoma cells results in coordinate loss of neuronal and malignant properties. Prog Clin Biol Res 271:265-276
5. Brodeur GM, Maris JM (2002) Neuroblastoma. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology. Lippincott Williams & Wilkins, Philadhelphia, pp 895-937
6. Bruey JM, Ducasse C, Bonniaud P, Ravagnan L, Susin SA, Diaz-Latoud C, Gurbuxani S, Arrigo AP, Kroemer G, Solary E, Garrido C (2000) Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol 2:645-652
7. Carta F, Demuro PP, Zanini C, Santona A, Castiglia D, D'Atri S, Ascierto PA, Napoletano M, Cossu A, Tavolini B, Turrini F, Manca A, Sini MC Palmieri G, Rozzo AC (2005) Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases. Melanoma Res 15:235-244
8. Charette SJ, Lavoie JN, Lambert H, Landry J (2000) Inhibition of Daxx-mediated apoptosis by heat shock protein 27. Mol Cell Biol 20:7602-7612
9. Cimmino F, Spano D, Capasso M, Zambrano N, Russo R, Zollo M, Iascolan A (2007) Comparative proteomic expression profile in all-trans retinoic acid differentiated neuroblastoma cell line. J Proteome Res 6:2550-2564
10. Ginsberg JP, Woo SY, Johnson ME, Hicks MJ, Horowitz ME (2002) Ewing's sarcoma family of tumors: Ewing's sarcoma of bone and soft tissue and the peripheral primitive neuroectodermal tumors. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology. Lippincott Williams & Wilkins, Philadhelphia, pp 937-1016
11. Giribaldi G, Ulliers D, Mannu F, Arese P, Turrini F (2001) Growth of Plasmodium falciparum induces stage-dependent haemichrome formation, oxidative aggregation of band 3, membrane deposition of complement and antibodies, and phagocytosis of parasitized erythrocytes. Br J Haematol 13:492-499
12. Harris MN, Ozpolat B, Abdi F, Gu S, Legler A, Mawuenyega KG, Tirado-Gomez M, Lopez-Berestein G, Chen X (2004) Comparative proteomic analysis of all-trans-retinoic acid treatment reveals systematic posttranscriptional control mechanisms in acute promyelocytic leukemia. Blood 104:1314-1323
13. Hasegawa SL, Davison JM, Rutten A, Fletcher JA, Fletcher CD (1998) Primary cutaneous Ewing's sarcoma: immunophenotypic and molecular cytogenetic evaluation of five cases. Am J Surg Pathol 22:310-8
14. Hoang AT, Huang J, Rudra-Ganguly N, Zheng J, Powell WC, Rabindran SK, Wu C, Roy-Burman P (2000) A novel association between the human heat shock transcription factor 1 (HSF1) and prostate adenocarcinoma. Am J Pathol 156:857-864
15. Ishiguro Y, Kato K, Akatsuka H, Iwata H, Nagaya M (1997) Chemotherapy-induced expression of alpha B-crystallin in neuroblastoma. Med Pediatr Oncol 29:11-5
16. Jolly C, Morimoto RI (2000) Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst 92:1564-1572
17. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408
18. Miyazaki T, Kato H, Faried A, Sohda M, Nakajima M, Fukai Y, Masuda R, Fukuchi M, Ojima H, Tsukada K, Kuwano H (2005) Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma. Anticancer Res 25:2749-2755
19. Oakley BR, Kirsch DR, Morris NR (1980) A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels. Anal Biochem 105:361-363
20. Peuchmaur M, d'Amore SG, Joshi VV, Hata J, Roald B, Dehner LP, Gerbing RB, Stram DO, Lukens JN, Matthay KK, Shimada H (2003) Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular. Cancer 98:2274-2281
21. Ponthan F, Borgstrom P, Hassan M, Wassberg E, Redfem CP, Kogner P (2001) The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo. Med Pediatr Oncol 36:127-131
22. Rane MJ, Pan Y, Singh S, Powell DW, Wu R, Cummins T, Chen Q, McLeish KR, Klein JB (2003) Heat shock protein 27 controls apoptosis by regulating Akt activation. J Biol Chem 278:27828-27835
23. Rettig WJ, Splenger BA, Chesa PG, Old LJ, Biedler JL (1987) Coordinate changes in neuronal phenotype and surface antigen expression in human neuroblastoma cell variants. Cancer Res 47:1383-1389
24. Rocchi P, Ferreri AM, Simone G, Prodi G (1987) Epirubicin-induced differentiation of human neuroblastoma cells in vitro. Anticancer Res 7:247-250
25. Sarto C, Valsecchi C, Magni F, Tremolada L, Arizzi C, Cordani N, Cesellato S, Doro G, Favoni P, Perego RA, Raimondo F, Ferrero S, Mocarelli P, Galli-Kienle M (2004) Expression of heat shock protein 27 in human renal cell carcinoma. Proteomics 4:2252-2260
26. Schlesinger HR, Gerson JM, Moorhead PS, Maguire H, Hummeler K (1976) Establishment and characterization of human neuroblastoma cell lines. Cancer Res 36:3094-3100
27. Schwab M, Shimada H, Joshi V, Brodeur GM (2000) Neuroblastic tumours of adrenal gland and sympathetic nervous system. In: Kleihues P, Canavee WK (eds) Pathology and genetics of tumours of the nervous system. IARC, Lyon, pp 153-161
28. SIOP (2004) Europe Neuroblastoma AIEOP LNESG2 Study: guidelines for the treatment of patients with localized resectable neuroblastoma and analysis of prognostic factors. Ist. G. Gaslini
29. Thanner F, Sutterlin MW, Kapp M, Rieger L, Morr AK, Kristen P, Dietl J, Gassel AM, Muller T (2005) Heat shock protein 27 is associated with decreased survival in node-negative breast cancer patients. Anticancer Res 25:1649-1653
30. Thiele CJ, McKeon C, Triche TJ, Ross RA Reynolds CP, Israel MA (1987) Differential protooncogene expression characterizes histopathologically indistinguishable tumors of the peripheral nervous system. J Clin Invest 80:804-811
31. Thomas X, Campos L, Mounier C, Cornillon J, Flandrin P, Le QH, Piselli S, Guyotat D (2005) Expression of heat-shock proteins is associated with major adverse prognostic factors in acute myeloid leukemia. Leuk Res 29:1049-1058
32. Triche T, Askin FB, Kissane JM (1986) Neuroblastoma, Ewing Sarcoma and the differential diagnosis of small- round- blue-cell tumor. In: Finegold M (ed) Pathology of neoplasia in children and adolescents. Sauders, Philadelphia, pp 145-195
33. Ungar DR, Hailat N Strahler JR, Kuick RD, Brodeur GM, Seeger RC, Reynolds CP, Hanash SM (1994) Hsp27 expression in neuroblastoma: correlation with disease stage. J Nat Can Inst 86:780-4
34. Ushigome S, Machinami R, Soresens PH (2002) Ewing sarcoma/primitive neuroectodermal tumour (PNET). In: Fletcher CDM, Unni KK, Mertens F (eds) Pathology and genetics of tumours of soft tissue and bone. IARC, Lyon, pp 298-300
35. Voight A, Zintl F (2003) Effects of retinoic acid on proliferation, apoptosis, cytotoxicity, migration, and invasion of neuroblastoma cells. Med Pediatr Oncol 40:205-213
36. Woolson RF, Clarke WR (2002) Statistical methods for the analysis of biomedical data, 2nd edn. Wiley, New York, pp 226-232, 286-288
37. Yenari MA (2002) Heat shock proteins and neuroprotection. Adv Exp Med Biol 513:281-289
38. Zanini C, Giribaldi G, Mandili G, Carta F, Crescenzio N, Bisaro B, Doria A, Foglia L, di Montezemolo LC, Timeus F, Turrini F (2007) Inhibition of heat shock proteins (HSP) expression by quercetin and differential doxorubicin sensitization in neuroblastoma and Ewing's sarcoma cell lines. J Neurochem 103:1344-1354